INFLARX N.V. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.54 USD | +7.69% |
|
+4.49% | -6.41% |
| 05-08 | InflaRx N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-21 | Transcript : InflaRx N.V. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INFLARX N.V. | Bio Therapeutic Drugs | +7.69% | +4.49% | -6.41% | -63.24% | -95.82% | 84.2M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- IFRX Stock
- Charts InflaRx N.V.
- Comparison Chart
